The hypermethylation and mRNA downregulation noted in the CMT tissue is however concurrent with previous studies where EPAS1 has been shown to be hypermethylated in its promotor with downregulated mRNA expression in non-small cell lung cancer [52] and colon cancer [47]. This evidence concerns the gene EPAS1 and malignant colon neoplasm.